Galderma Group AG closed out Q1 2026 with net sales of $1.5 billion. The gains were predominantly driven by volume and complemented by positive price and mix effects, underscoring the continued execution of its unique, growth-driven integrated dermatology strategy, officials said. Widespread net sales growth of were 25.5% year-on-year at constant currency, aligned with strong growth performance across geographies and product categories, including Dermatological Skincare at an increase of 1...